INTRODUCTION
Tumor angiogenesis is an extremely complex process in which tumor cells, either in response to hypoxia or through genetic modifications associated with malignancy, secrete a number of stimulatory cytokines, of which the vascular endothelial growth factor (VEGF) is the most often associated with the onset of angiogenesis [1] . The binding of VEGF to the VEGFR-1 (Flt-1) and VEGFR-2 (Flk-1) receptors at the endothelial cell (EC) surface triggers a number of intracellular signaling events that ultimately lead to increased proliferation, migration and survival of the EC [2] . In addition, VEGF is a potent inducer of vascular permeability, resulting in the extravasation of plasma fibrinogen in the extravascular space, which is then clotted to a cross-linked fibrin provisional matrix via the proteolytic action of thrombin [3] . This fibrin matrix appears to be essential for neovascularization, allowing migration of the activated EC towards the chemotactic stimulus as well as by acting as an essential substrate for the morphogenesis of EC into tubular structures [4] . Since new vessels are highly permeable, fibrin is continuously present into the tumor stroma and triggers the activation of the coagulation system [5] . The important role of fibrin deposition and degradation in neovessel formation thus highlights the crucial function of the hemostatic system in the regulation of angiogenesis and tumor growth [6, 7] .
Fibrin matrices form three-dimensional scaffolds that provide cell-attachment sites and mechanical support for invading EC but also act as a barrier through which EC must penetrate to facilitate the formation of new capillaries [8] . The proteolytic degradation of inserm-00383800, version 1 -3 Jul 2009 inserm-00383800, version 1 -3 Jul 2009 this fibrin matrix can be mediated by plasmin, a potent fibrinolytic enzyme which is activated from its zymogen plasminogen urokinase-and tissue-type plasminogen activators [9] . Several studies have shown that uPA-mediated plasmin generation plays important roles in cell migration, tissue remodelling, and in angiogenesis and tumor growth [10] [11] [12] . Although the role of tPA-mediated plasmin activation in angiogenesis is much less understood, the activity of t-PA correlates with a poor prognosis in several cancers [13, 14] and, at least in some cases, its overexpression promotes growth and angiogenesis in vitro and in vivo [15] .
In spite of the importance of PA-mediated plasmin formation for fibrin degradation, mice lacking either uPA, tPA or plasminogen show no significant alteration in the neovascularization of fibrin-rich tissues [16] . It was subsequently shown that EC from these animals retain the ability to invade fibrin matrices due to the pericellular fibrinolysis mediated by membrane type MMPs [17, 18] . Such an important role of membrane-anchored MMPs in fibrinolysis is also suggested by the ability of EC to undergo plasmin-independent tubulogenesis within fibrin gels, a property most likely related to an increased expression of MT1-, MT2-and MT3-MMP [19] . In the presence of plasminogen, however, both plasmin and MMP activities were required for efficient invasion of fibrin matrices [20] . These observations thus suggest the existence of a complex relationship between the PA/plasminogen and MMP proteolytic systems that may be modulated by the microenvironment surrounding the EC.
In order to study in more details the mechanisms involved in EC-mediated fibrin degradation, we used an in vitro fibrinolysis model consisting of human vascular endothelial cells embedded in a three dimensional fibrin matrix in the presence of [21] , leading to distinct patterns of signal transduction and of gene expression [22] .
Using this cell system, we observed that the angiogenic cytokine VEGF markedly increases the fibrinolytic activity of endothelial cells, this effect occurring through a VEGFR-2-dependent activation of both plasminogen activator and metalloprotease proteolytic systems. This VEGF-induced fibrinolysis by endothelial cells depends on the synthesis and activity of tPA and is correlated with the up-regulation of membraneassociated members of the MMP family, MT-MMPs. 
MATERIALS AND METHODS

Materials
Plasminogen-free human fibrinogen, recombinant human PAI-1 and human plasmin were obtained from Calbiochem (La Jolla, CA). 
In vitro fibrinolysis assay
HUVECs were embedded within fibrin gels at a concentration of 1.2 x 10 6 cells/ml. Cells were centrifuged gently at 1000 rpm for 3 min in 14 ml tubes and the cell pellet resuspended in a mixture of 2.5 mg/ml plasminogen-free human fibrinogen and 125 I radiolabeled human fibrinogen (0.15 µCi/ml) (made in serum-free medium). Thrombin (0.5 U/ml) was then added to the fibrinogen mixture, quickly pipetted into the wells of a 24-well plate (300 µl, covering the entire surface of the wells) and allowed to clot at 37°C for 30 min. After washing, EC medium containing 1 % serum was added to the wells in the presence of angiogenic factors in order to induce fibrinolysis. For inhibition studies, protease inhibitors, PTK787, cycloheximide and antibodies were also added to the gels (prior to polymerization) and to the culture medium. Fibrin gels were incubated for several days at 37°C and 5% CO 2 (v/v) and radiolabeled solubilized fibrin degradation products released in the media were quantified by γ scintillation counting. The spontaneous release of 125 I-fibrin fragments from gels incubated in the presence of serumfree medium, which represented less than 5 % of the measured signal, was used as a control. Fibrin gels were also incubated in the presence of DMSO to assess the effect of vehicle for BB94 and PTK787.
Fibrinogen and plasminogen zymography assay
Plasmin generation in the medium was detected by fibrinogen zymography. Culture media (40 µl) or plasmin (positive control) were resolved under nonreducing conditions on 7.5% SDS-PAGE gels containing 1 mg/ml plasminogen-free fibrinogen. Gels were rinsed two times in 2.5% Triton X-100 for 30 min at room temperature to remove SDS, and the gels were further incubated at 37 °C for 48 h in 20 mM NaCl, 5 mM CaCl 2 , 0.02% Brij-35, 50 mM Tris-HCl buffer, pH 7.6. Gels were stained with Coomassie Blue, and destained in 10% (v/v) acetic acid/30% methanol. Areas of fibrinogenolytic activity were visualized as transparent bands.
The activity of uPA and tPA secreted into the culture medium was assessed by casein/plasminogen zymography [24] . Briefly, conditioned media were separated by SDS-PAGE under nonreducing conditions on a 7.5% acrylamide gel containing 1 mg/ml casein and 10 mg/ml human plasminogen. Electrophoresis was performed at 4 o C and the resulting gels were washed twice for 30 min in 2.5% (v/v) Triton X-100 at room temperature and rinsed five times with nanopure water. Gels were incubated at 37°C in casein-plasminogen buffer (100 mM Tris-HCl, pH 8.0, 50 mM EDTA) for 3 h.
Plasminogen-dependent proteolysis was detected as a clear zone following staining with 0.1% (w/v) Coomassie blue R-250 in 10% acetic acid/40% methanol and destaining in 7.5% acetic acid/30% methanol.
RNA extraction and reverse transcription and polymerase chain reaction (RT-PCR)
To isolate RNA from HUVEC within fibrin gels, cells were embedded as described above except that the fibrin solution was quickly pipetted into the wells of a 12-well plate (570 µl) and allowed to clot at 37°C for 30 min. After washing, serum-containing EC medium was added to the wells. The cells were incubated for 18 h at 37°C and 5% CO 2 (v/v). VEGF was then added for 4 h and total RNA was isolated by solubilizing the gels with the TRIzol Reagent, according to the instructions of the manufacturer. RNA was In order to study the fibrinolytic activity of EC, we used a three dimensional cell culture model in which HUVEC were embedded in a radiolabeled fibrin gel, allowing a rapid and sensitive monitoring of fibrinolytic activity by liquid scintillation counting of fibrin fragments released in the cell culture medium.
We first used this model to evaluate the effect of various angiogenic factors on fibrin degradation by EC. As shown in Fig. 1A , serum alone had no effect on fibrinolysis but we observed that the addition of VEGF to the cell culture medium promoted a marked increase in the release of labeled fibrin fragments. This stimulatory effect was also observed for HGF/SF, albeit to a lower extent, while EGF, PDGF, bFGF or the lysophospholipids S1P and LPA had negligeable activities. The VEGF-dependent fibrinolytic activity of HUVECs was observed at concentrations as low as 25 ng/mL, reaching a maximum at 50 ng/mL (Fig. 1B) .
VEGF-induced fibrinolytic activity of endothelial cells within a fibrin gel involves VEGFR-2.
At the endothelial cell surface, VEGF binds to two receptors, VEGFR-1 and VEGFR-2, the latter being responsible for the majority of the biological responses associated with VEGF [25] . To determine the involvement of this receptor, we first examined the effect These results thus suggest that under the experimental conditions used in our study, the VEGF-dependent fibrin degradation by HUVEC is dependent on both plasmin and MMP activity.
Since a previous study has reported that tubulogenesis by EC embedded in a three dimensional fibrin matrix does not involve plasmin activity [19] , we next determined whether the observed requirement for plasmin was related to an increased secretion of plasminogen activators by EC stimulated with VEGF. Cells were treated with VEGF in the absence or in the presence of inhibitors of the MMP or plasminogen activator/plasmin systems and the secretion of plasminogen activators and production of plasmin were monitored by plasminogen and fibrinogen zymography, respectively. As shown in Fig.   3B , VEGF induced an approximatively 2-fold increase in the secretion of tPA by HUVEC while that of uPA was much less modulated by the growth factor. As expected, the inhibition of VEGFR-2 activity using PTK787 completely abolished the release of tPA in the medium and reduced that of uPA, again emphasizing the important role of the VEGF signaling pathway in fibrinolysis. The addition of the physiological inhibitor tPA and uPA inhibitor PAI-1 also markedly decreased the secretion of tPA and uPA. By contrast, the inhibition of MMP activities by BB-94 as well as by TIMP-2 (data not shown) had no effect on the VEGF-induced release of tPA.
Fibrinogen zymography analysis confirmed that the increased secretion of tPA leads to the generation of plasmin in the culture medium. As shown in Fig. 3C , the addition of VEGF led to the time-dependent appeareance of plasmin activity in the medium, this increase being completely inhibited by PTK787 and PAI-1. Interestingly, we observed that in spite of its lack of inhibitory effect on the release of tPA, BB-94 nevertheless completely inhibited plasmin generation, suggesting that the observed inhibitory effect of this inhibitor on fibrinolysis may be related to its interference with the plasminogen activator-dependent conversion of plasminogen to plasmin.
VEGF-induced fibrinolytic activity of endothelial cells correlates with increased mRNA for tPA and MT2-MMP.
The VEGF-dependent increase in fibrinolysis was found to be highly sensitive to cycloheximide, a protein synthesis inhibitor, suggesting that it involves de novo synthesis of components of the fibrinolytic proteolytic pathway (Fig. 4A) . To preliminary characterize the proteins involved, we isolated total RNA from HUVEC embedded in the fibrin matrix and monitored the variation in mRNA levels of tPA, uPA and of membrane-type MMPs following a 4 h stimulation of the cells with VEGF. As shown in Fig. 4B , VEGF induced a marked increase in the mRNA levels of tPA while those of uPA were not significantly modulated by the treatment. Interestingly, the inhibitory profile of inhibitors on mRNA levels parallels that previously observed for the inhibition of the secretion of plasminogen activators by HUVEC (Fig. 3B ) since PTK787 and PAI-1, but not BB-94, completely inhibited the VEGF-dependent induction of tPA mRNA levels (Fig. 4B) . These results thus strongly suggest that tPA is the predominant PA involved in the VEGF-dependent fibrinolytic activity of HUVEC in a three dimensional fibrin matrix, an hypothesis strongly supported by the complete inhibition of release of fibrin fragments by a function-blocking monoclonal antibody that specifically recognize the enzyme (Fig. 4C) . 
DISCUSSION
Fibrin matrices play essential roles in the initiation and propagation of angiogenic responses by serving as a provisional matrix that sustains the formation of neovessels [28] . However, the dense cross-linked structure of fibrin also represents a major obstacle for endothelial cell locomotion and EC rely on the fibrinolytic activities of the plasminogen activator/plasmin and MMP proteolytic systems to invade fibrin networks [8] . The interrelationship between these systems appears complex since fibrinolysis was found to be critically dependent on either uPA/plasmin activity [11, 12] , MMP activities [17, 19] or on both classes of proteases [20, 29] . It is thus likely that the reliance on MMP-versus plasmin-dependent fibrin degradation may depend on the microenvironment surrounding the blood vessels , especially the biochemical nature of the angiogenic stimuli [17] .
In order to study the factors involved in the control of EC-mediated fibrinolysis, we used a model in which EC are embedded in a three dimensional fibrin matrix in the presence of plasminogen from the culture medium. Under these conditions, we observed that fibrinolysis was critically dependent on the presence of VEGF and involves both the PA/plasminogen and MMP proteolytic systems. We observed that stimulation of EC with VEGF induced an increase in the tPA levels but not those of uPA, in agreement with previous studies showing that VEGF is a much more potent inducer of t-PA than of uPA in bovine microvascular endothelial cells, at both the mRNA and protein levels [30, 31] .
This increase in the levels of tPA seems crucial in terms of fibrinolysis since a function- In addition to the important role of tPA-mediated plasmin formation for the VEGFinduced fibrin degradation by HUVEC, we also observed that this process was highly dependent on MMP activity. Fibrinolysis was completely abolished by BB-94, a broad spectrum inhibitor of MMP as well as by the addition of low concentrations of TIMP-2, a physiological MMP inhibitor. This inhibitory effect of MMP inhibitors is not related to an interference with the VEGF-dependent increase in the tPA mRNA levels nor on its release in the culture medium but rather with the formation of plasmin in the culture medium. This strongly suggests the involvement of the MMP activity in the tPAdependent conversion of plasminogen to plasmin. In this respect, it is noteworthy that a recent report has documented the MMP-dependent activation of pro-uPA to active uPA following VEGF stimulation of HUVEC, this process involving a rapid and posttranslational (cycloheximide-insensitive) PI3-kinase-dependent activation of integrinassociated proMMP-2 [29] . Such a mechanism is however unlikely to play a significant role under our experimental conditions since we observed that fibrinolysis rather these MMPs could generate binding sites for plasminogen to fibrin, leading to enhanced plasmin production and fibrinolysis [32] .
The requirement for tPA in EC-mediated fibrinolysis was unexpected since uPA was previously shown to play essential roles in the invasion of fibrin matrices by EC of human origin [11, 12] and is generally considered the most prominent PA involved in EC invasive properties [33] . Although the role of tPA in angiogenesis remains much less understood, it has been suggested that its release from Weibel-Palade bodies may prevent fibrin deposition in coagulation-prone neovessels [8, 33] . In support to this hypothesis, the VEGF-dependent induction of tPA in bovine microvascular cells resulted in the localization of the enzyme in Weibel-Palade bodies [34] and VEGF was recently shown to activate Weibel-Palade bodies exocytosis [35] . However, the involvement of this pathway in the tPA-dependent fibrinolysis observed in our study is unlikely since VEGFinduced exocytosis occurs within 5 minutes of stimulation, in agreement with its role in the immediate response of EC to injury, independent of gene transcription [36] . S1P, another activator of Weibel-Palade body exocytosis [37] had no stimulatory effect on fibrinolysis, further suggesting that this process is not involved in the observed degradation of fibrin.
In summary, our results suggest that endothelial cells embedded in a three dimensional fibrin matrix express a complex proteolytic repertoire upon stimulation with VEGF, of which tPA is a prominent regulator of pericellular fibrinolysis. Since plasmin(ogen)-enhanced invasion by endothelial cells is blocked by both angiostatin and anti-catalytic t-PA antibodies [38] , it is tempting to speculate that the observed increased (50 nM to 1 µM) for 3 h in standard serum-containing medium and then VEGF (1 nM final concentration) and/or PTK787 were added to the medium. The cells were incubated at 37°C and 5% CO 2 (v/v) for 48 h and the extent of fibrinolysis monitored as described above. zymography of culture media were performed as described in "Materials and Methods", using commercial preparations of tPA, uPA and plasmin as standrads. 
